Structure-Activity Relationship of USP5 Inhibitors.
Mandeep K MannCarlos A Zepeda-VelázquezHéctor González-ÁlvarezAiping DongTaira KiyotaAhmed M AmanPeter LoppnauYanjun LiBrian WilsonCheryl H ArrowsmithRima Al-AwarRachel J HardingMatthieu SchapiraPublished in: Journal of medicinal chemistry (2021)
USP5 is a deubiquitinase that has been implicated in a range of diseases, including cancer, but no USP5-targeting chemical probe has been reported to date. Here, we present the progression of a chemical series that occupies the C-terminal ubiquitin-binding site of a poorly characterized zinc-finger ubiquitin binding domain (ZnF-UBD) of USP5 and competitively inhibits the catalytic activity of the enzyme. Exploration of the structure-activity relationship, complemented with crystallographic characterization of the ZnF-UBD bound to multiple ligands, led to the identification of 64, which binds to the USP5 ZnF-UBD with a KD of 2.8 μM and is selective over nine proteins containing structurally similar ZnF-UBD domains. 64 inhibits the USP5 catalytic cleavage of a di-ubiquitin substrate in an in vitro assay. This study provides a chemical and structural framework for the discovery of a chemical probe to delineate USP5 function in cells.
Keyphrases
- structure activity relationship
- small molecule
- high throughput
- induced apoptosis
- quantum dots
- escherichia coli
- papillary thyroid
- dna binding
- cell death
- drug delivery
- cystic fibrosis
- pseudomonas aeruginosa
- young adults
- staphylococcus aureus
- transcription factor
- signaling pathway
- single cell
- binding protein
- oxide nanoparticles